Use of oral anticoagulation among stroke patients with atrial fibrillation in China: The ChinaQUEST (Quality evaluation of stroke care and treatment) registry study

International Journal of Stroke

Volumn 8, Issue 3, 2013, Pages 150-154

  Gao, Qingchun ^a   Fu, Xian ^a   Wei, Jade W ^b   Chen, Xiangyan ^c   Huang, Yining ^d   Wang, Jiguang ^e   Anderson, Craig S ^b   Wong, Ka Sing ^c  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d PEKING UNIVERSITY FIRST HOSPITAL   (China)

^e SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; China; Oral anticoagulation; Stroke

Indexed keywords

WARFARIN;

AGE DISTRIBUTION; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CHINA; DRUG USE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INCOME; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OCCUPATION; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADMINISTRATION, ORAL; AGE FACTORS; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CHINA; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; STROKE; WARFARIN;

EID: 84875259860     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00716.x     Document Type: Article

References (16)

1. Bernstein RA, Passman R. Prevention of stroke in patients with high-risk atrial fibrillation. Curr Neurol Neurosci Rep 2010; 10:34-39.
2. Audebert HJ, Schenk B, Schenkel J, Heuschmann PU. Impact of prestroke oral anticoagulation on severity and outcome of ischemic and hemorrhagic stroke in patients with atrial fibrillation. Cerebrovasc Dis 2010; 29:476-483.
3. Schwammenthal Y, Bornstein N, Schwammenthal E etal. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey (NASIS)). Am J Cardiol 2010; 105:411-416.
4. Elezi S, Qerkini G, Bujupi L, Shabani D, Bajraktari G. Management and comorbidities of atrial fibrillation in patients admitted in cardiology service in Kosovo - a single-center study. Anadolu Kardiyol Derg 2010; 600:36-40.
5. Ruiz Ortiz M, Romo E, Mesa D etal. Oral anticoagulation in nonvalvular atrial fibrillation in clinical practice: impact of CHADS(2) score on outcome. Cardiology 2010; 115:200-204.
6. Zimetbaum PJ, Thosani A, Yu HT etal. Are atrial fibrillation patients receiving warfarin in accordance with stroke risk? Am J Med 2010; 123:446-453.
7. Tulner LR, Van Campen JP, Kuper IM etal. Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study. Drugs Aging 2010; 27:39-50.
8. Mant J, Hobbs F, Fletcher K etal. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370:493-503.
9. Heeley E, Anderson CS, Huang Y etal. Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke 2009; 40:2149-2156.
10. Control CCfD, Division CMAN (eds) China Guideline for Cerebrovascular Disease Prevention and Treatment. Beijing, People's Medical Publishing House, 2007.
11. Inoue H, Nozawa T, Hirai T etal. Sex-related differences in the risk factor profile and medications of patients with atrial fibrillation recruited in J-TRACE. Circ J 2010; 74:650-654.
12. Hylek E, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007; 115:2689-2696.
13. Poli D, Antonucci E, Marcucci R etal. Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score. Thromb Res 2007; 121:347-352.
14. DiMarco J, Flaker G, Waldo A etal. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005; 149:650-656.
15. Hughes M, Lip GY. Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. QJM 2007; 100:599-607.
16. Klungel OH, de Boer A, Paes AH, Herings RM, Seidell JC, Bakker A. Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in the Netherlands. Pharm World Sci 1999; 21:217-220.